Convergent genetic and expression data implicate immunity in Alzheimer's disease.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Jones, LLambert, JC
Wang, LS
Choi, SH
Harold, D
Vedernikov, A
Escott-Price, V
Stone, T
Richards, A
Bellenguez,
Ibrahim-Verbaas, CA
Naj, AC
Sims, R
Gerrish, A
Jun, G
DeStefano, AL
Bis, JC
Beecham, GW
Grenier-Boley, B
Russo, G
Thornton-Wells TA
Jones, N
Smith, AV
Chouraki, V
Thomas, C
Ikram, MA
Zelenika, D
Vardarajan, BN
Kamatani, Y
Lin, CF
Schmidt, H
Kunkle, BW
Dunstan, ML
Ruiz, A
Bihoreau, MT
Reitz, C
Pasquier, F
Hollingworth, P
Hanon, O
Fitzpatrick, AL
Buxbaum, JD
Campion, D
Crane, PK
Becker, T
Gudnason, V
Cruchaga, C
Craig, D
Amin, N
Berr, C
Lopez, OL
De Jager, PL
Deramecourt, V
Johnston, JA
Evans, D
Lovestone, S
Letteneur, L
Kornhuber, J
Tarraga, L
Rubinsztein, DC
Eiriksdottir, G
Sleegers, K
Goate, AM
Fievet, N
Huentelman, MJ
Gill, M
Emilsson, V
Brown, K
Kamboh, MI
Keller, L
Barberger-Gateau, P
McGuinness, B
Larson, EB
Myers, AJ
Dufouil, C
Todd, S
Wallon, D
Love, S
Kehoe, P
Rogaeva, E
Gallacher, J
St George-Hyslop, P
Clarimon, J
Lleo, A
Bayer, A
Tsuang, DW
Yu, L
Tsolaki, M
Bossu, P
Spalletta, G
Proitsi, P
Collinge, J
Sorbi, S
Garcia, FS
Fox, N
Hardy, J
Naranjo, MCD
Razquin, C
Bosco, P
Clarke, R
Brayne, C
Galimberti, D
Mancuso, M
Moebus, S
Mecocci, P
del Zompo, M
Maier, W
Hampel, H
Pilotto, A
Bullido, M
Panza, F
Caffarra, P
Nacmias, B
Gilbert, JR
Mayhaus, M
Jessen, F
Dichgans, M
Lannfelt, L
Hakon, H
Pichler, S
Carrasquillo, MM
Ingelsson, M
Beekly, D
Alavarez, V
Zou, FG
Valladares, O
Younkin, SG
Coto, E
Hamilton-Nelson, KL
Mateo, I
Owen, MJ
Faber, KM
Jonsson, PV
Combarros, O
O'Donovan
MC Cantwell, LB
Soininen, H
Blacker, D
Mead, S
Mosley, TH
Bennett, DA
Harris, TB
Fratiglioni, L
Holmes, C
de Bruijn, RFAG
Passmore, P
Montine, TJ
Bettens, K
Rotter, JI
Brice, A
Morgan, K
Foroud, TM
Kukull, WA
Hannequin, D
Powell, JF
Nails, MA
Ritchie, K
Lunetta, KL
Kauwe, JSK
Boerwinkle, E
Riemenschneider, M
Boada, M
Hiltunen, M
Martin, ER
Pastor, P
Schmidt, R
Rujescu, D
Dartigues, JF
Mayeux, R
Tzourio, C
Hofman, A
Nothen, MM
Graff, C
Psaty, BM
Haines, JL
Lathrop, M
Pericak-Vance, MA
Launer, LJ
Farrer, LA
van Duijn, CM
Van Broeckhoven, C
Ramirez, A
Schellenberg, GD
Seshadri, S
Amouyel, P
Williams, J
Holmans, PA
Issue Date
2015-06
Metadata
Show full item recordCitation
Alzheimers Dement. 2015, 11 (6):658-71Abstract
Late-onset Alzheimer's disease (AD) is heritable with 20 genes showing genome-wide association in the International Genomics of Alzheimer's Project (IGAP). To identify the biology underlying the disease, we extended these genetic data in a pathway analysis.The ALIGATOR and GSEA algorithms were used in the IGAP data to identify associated functional pathways and correlated gene expression networks in human brain.
ALIGATOR identified an excess of curated biological pathways showing enrichment of association. Enriched areas of biology included the immune response (P = 3.27 × 10(-12) after multiple testing correction for pathways), regulation of endocytosis (P = 1.31 × 10(-11)), cholesterol transport (P = 2.96 × 10(-9)), and proteasome-ubiquitin activity (P = 1.34 × 10(-6)). Correlated gene expression analysis identified four significant network modules, all related to the immune response (corrected P = .002-.05).
The immune response, regulation of endocytosis, cholesterol transport, and protein ubiquitination represent prime targets for AD therapeutics.
Description
To access publisher's full text version of this article click on the hyperlink at the bottom of the pageAdditional Links
http://dx.doi.org/ 10.1016/j.jalz.2014.05.1757Rights
Archived with thanks to Alzheimer's & dementia : the journal of the Alzheimer's Associationae974a485f413a2113503eed53cd6c53
10.1016/j.jalz.2014.05.1757
Scopus Count
Collections
Related articles
- Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.
- Authors: Gao S, Casey AE, Sargeant TJ, Mäkinen VP
- Issue date: 2018 Sep 1
- The GWAS Risk Genes for Depression May Be Actively Involved in Alzheimer's Disease.
- Authors: Ni H, Xu M, Zhan GL, Fan Y, Zhou H, Jiang HY, Lu WH, Tan L, Zhang DF, Yao YG, Zhang C
- Issue date: 2018
- Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
- Authors: Hu YS, Xin J, Hu Y, Zhang L, Wang J
- Issue date: 2017 Apr 27
- Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
- Authors: Wang M, Roussos P, McKenzie A, Zhou X, Kajiwara Y, Brennand KJ, De Luca GC, Crary JF, Casaccia P, Buxbaum JD, Ehrlich M, Gandy S, Goate A, Katsel P, Schadt E, Haroutunian V, Zhang B
- Issue date: 2016 Nov 1
- Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.
- Authors: Andrews SJ, Fulton-Howard B, Goate A
- Issue date: 2020 Apr